Lv11
94 积分 2025-02-06 加入
Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway
10天前
已完结
Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1
11天前
已完结
Intestinal fatty acid binding protein: A rising therapeutic target in lipid metabolism
11天前
已完结
Cirrhotic Cardiomyopathy
23天前
已完结
Mechanistic insights into the pathophysiology of cirrhotic cardiomyopathy
24天前
已完结
Review article: comprehensive analysis of cirrhotic cardiomyopathy
24天前
已完结
Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in mice
1个月前
已完结
Dual inhibition of hepatic ACLY and ACSS2: a synergistic approach to combat NAFLD through lipogenesis reduction and mitochondrial enhancement
1个月前
已完结
A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)
1个月前
已完结
Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
1个月前
已完结
皖公网安备34019202002308
